Universitair Ziekenhuis GentGhent, Belgium
N/A
(1546171) Epcoritamab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results From the Phase 1b/2 EPCORE CLL-1 Trial Expansion Cohort
Sunday, October 8, 20232:45 PM – 2:55 PM EDT